The PI3K Inhibitor XH30 Enhances Response to Temozolomide in Drug-Resistant Glioblastoma via the Noncanonical Hedgehog Signaling Pathway

Ming Ji(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoguang Chen(Macau University of Science and Technology)
Frontiers in Pharmacology
November 26, 2021
Cited by 12


Related Papers